Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cavitation Technologies (CVAT) Shares Outstanding (Weighted Average) (2016 - 2025)

Cavitation Technologies (CVAT) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $35.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 10.62% to $35.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.3 million through Dec 2025, down 10.62% year-over-year, with the annual reading at $286.0 million for FY2025, 891.64% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $35.3 million in Q4 2025 for Cavitation Technologies, down from $289.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $289.2 million in Q3 2025 to a low of $23.8 million in Q3 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $118.0 million across 5 years, with a median of $61.4 million in 2022.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): plummeted 89.06% in 2023 and later skyrocketed 902.58% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $232.7 million in 2021, then increased by 18.91% to $276.7 million in 2022, then tumbled by 89.06% to $30.3 million in 2023, then skyrocketed by 30.67% to $39.5 million in 2024, then dropped by 10.62% to $35.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CVAT at $35.3 million in Q4 2025, $289.2 million in Q3 2025, and $49.0 million in Q2 2025.